Education
About Us
Working with TipRanks
Follow Us
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 922.22M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 922.22M | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ 266.46M | $ -5.56M | $ -3.16M | $ -3.17M |
| EBITDA | $ 266.46M | $ -324.00K | $ -1.43M | $ -4.38K |
| Net Income | $ 198.43M | $ -535.00K | $ -4.89M | $ -3.66M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 554.00K | $ 4.23M | $ 345.78K | $ 48.55K |
| Total Assets | $ 4.19M | $ 7.22M | $ 5.00K | $ 213.13K |
| Total Debt | $ 7.46M | $ 985.00K | $ 2.01M | $ 749.00K |
| Net Debt | $ 6.90M | $ -3.24M | $ 1.66M | $ 700.45K |
| Total Liabilities | $ 10.99M | $ 7.68M | $ 10.08M | $ 5.94M |
| Stockholders' Equity | $ -6.79M | $ -457.00K | $ -10.08M | $ -5.94M |
| Cash Flow | ||||
| Free Cash Flow | $ -9.73M | $ -7.72M | $ -2.27M | $ -2.15M |
| Operating Cash Flow | $ -9.68M | $ -7.72M | $ -2.27M | $ -2.15M |
| Investing Cash Flow | $ -43.00K | $ 725.00K | $ -183.00K | $ 48.55K |
| Financing Cash Flow | $ 6.07M | $ 10.93M | $ 2.45M | $ 1.90M |
Conduit Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.